GlassScriptPhysician profile
Lori D Warren
NPI 1962719633
$3,044.92
in general payments reported to CMS, 2019-2025
19 companies · $344 in 2025
The $344 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $974 · 2022: $400 · 2023: $710 · 2024: $617 · 2025: $344.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,672.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,671.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $560.72 | 2023-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Sapien 3 Ultra Resilia |
| Abbott Laboratories | $470.69 | 2021-2023 | Mitraclip |
| Astrazeneca Pharmaceuticals LP | $392.83 | 2021-2024 | Farxiga, Breztri |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $236.85 | 2021-2025 | Lifevest |
| Amgen INC. | $236.82 | 2021-2022 | |
| W. L. Gore & Associates, INC. | $147.85 | 2024 | Gore Cardioform Septal Occluder |
| Impulse Dynamics (USA) INC. | $147.58 | 2024 | Optimizer |
| Silk Road Medical, INC. | $136.75 | 2023 | Enroute Transcarotid Stent, Enroute Transcarotid Neuroprotection System |
| Janssen Pharmaceuticals, INC | $128.58 | 2021-2022 | |
| Pfizer INC. | $116.90 | 2021-2025 | |
| Atricure, INC. | $110.13 | 2021 | |
| Biosense Webster, INC. | $100.99 | 2024 | Carto 3 |
| Boehringer Ingelheim Pharmaceuticals, INC. | $83.05 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $58.97 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $38.29 | 2021-2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kestra Medical Technology Services, INC. | $29.57 | 2025 | Assure Wcd |
| Amryt Pharma Holdings LTD | $18.64 | 2021 | |
| Cvrx, INC. | $17.68 | 2024 | Barostim Neo System |
| E.R. Squibb & Sons, L.L.C. | $12.03 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lori Warren listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.